ReviewBreast cancer research : BCR2016

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers.

Richard S Finn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.